Sign in

You're signed outSign in or to get full access.

American Well (AMWL)

Earnings summaries and quarterly performance for American Well.

Recent press releases and 8-K filings for AMWL.

AmWell Reports Q3 2025 Results, Updates Full-Year Guidance, and Reaffirms 2026 Cash Flow Break-Even Goal
AMWL
Earnings
Guidance Update
Layoffs
  • AmWell reported Q3 2025 total revenue of $56.3 million, an 8% decrease year over year, though normalizing for the sale of APC, revenue would have increased by 1.3%. Subscription revenue grew 18% year over year to $30.9 million, comprising 55% of total revenue.
  • The company significantly improved its profitability, reporting an Adjusted EBITDA loss of $12.7 million for Q3 2025, compared favorably to a loss of $31 million a year ago, primarily due to a 16% decrease in operating expenses and cost containment initiatives.
  • AmWell updated its full-year 2025 revenue guidance to between $245 million and $248 million and narrowed its Adjusted EBITDA guidance to a loss between $45 million and $42 million. The company maintains its goal of achieving cash flow break-even from operations during 2026.
  • The company ended Q3 2025 with approximately $201 million in cash and marketable securities and zero debt, with a cash burn of approximately $18 million for the quarter. Strategic efforts include focusing on its new platform, integrating AI, and pursuing further divestiture of non-core assets.
Nov 4, 2025, 10:00 PM
American Well Corporation Announces Q3 2025 Financial Results and Updates Guidance
AMWL
Earnings
Guidance Update
  • American Well Corporation reported Total Revenue of $56.3 million for the third quarter ended September 30, 2025, with a net loss of ($31.9) million and Adjusted EBITDA of ($12.7) million.
  • The company updated its 2025 revenue guidance to a range of $245 million to $248 million and narrowed its Adjusted EBITDA guidance to between ($45) million to ($42) million.
  • For the fourth quarter of 2025, Amwell expects revenue in the range of $51 million to $54 million and Adjusted EBITDA in the range of ($15) million to ($12) million.
  • Amwell also reiterated its objective to achieve positive cash flow from operations in 2026.
Nov 4, 2025, 9:13 PM